Defending that 1.11 beautifully!

$BFRI

RNAI stocks are going to be the biggest driver in biotech in the through 2030 WAVE and PRQR
These could be the next ALNY
450 drugs in the pipeline worldwide for RNAI drugs.

$WVE

$7.60-59.23
https://www.harrow.com/
What a growth story will hold till the end of next year buyout in 2025


$HROW

Way overblown on the hair color change & neutropenia side effects from the trial should of waited a little bit longer will buy more they want to play mind games and bring it down the 52 week low. Great Team CASH to fund through phase 3 and a molecule that is next level.

Celldex ACAAI 12 Week CIndU Conference Call & Webcast
Oct 28, 2024 at 8:00 AM EDT
https://ir.celldex.com/static-files/86311fa1-d1e8-45b7-ad38-d557ff40c836


$CLDX

Hold 1.11 please could see a stop loss raid happen to steal shares from the weak minded a juke move to the dollar sub $1.00 area is possible lets hope not. Either way you have some relentless bears trying to the pin the stock down. Patience and Long term perspective =success. Great product dismal management team.


$BFRI

Doubling my position here today!

Love this technology and team

$PRQR

The lawsuit is in process I don't know much about it. Honestly not that concerned about it. It might tweak their earnings a little bit with the $5 million spend between BFRI and their subsidiary. They have about some cash not much would like to see a private placement and not offering at this time. Holding 225k shares not one of my core positions but it's free would like to see it hold 1.11 area for now.

I have called the company and told them to put up a Business Presentation if anyone else would like to call and suggest them to create one that would be great.
phone 781-245-1325 Not that impressed with the executive team but that's OK they have a product that works! I also don't understand the guy from Bench mark on their Board of Directors seems un ethical John J Borer what a dweeb. Company needs to do some house cleaning.

Hermann Lübbert | Biofrontera LOL

I would be shocked if the CFO did an offering at these levels.

I think partnership or buyout with Madrigal is in the works.

Core Holding!

$SGMT

Biofrontera AG has been sued by a USA competitor with the argument that Biofrontera infringes some competitors' lamps patents.

https://www.biofrontera.com/en/investors/financial-announcements/ad-hoc-news/pta-adhoc-biofrontera-ag-legal-dispute-on-import-in-the-usa-and-resulting-revised-outlook

Need to get this lawsuit Resolved a competitor is suing Biofronteria just stumbled across this from a friend of mine. I'm riding free shares houses money significant amount but I believe a Buyout or Merger happens soon. Not that concerned about this will hold until buyout or Merger.

Biofrontera AG: Legal dispute on import in the USA and resulting revised outlook



Public disclosure of inside information according to article.

Leverkusen, Germany (pta008/21.07.2024/14:45) - Biofrontera AG has been sued by a USA competitor with the argument that Biofrontera infringes some competitors' lamps patents.

The competitor has filed two different processes, one for two patent infringements in front of the district court, and a second one before the ITC (International Trade Commission), aiming to prohibit the import in the USA of Biofrontera XL Lamp.

Biofrontera has requested initial legal advice and is currently in the process of evaluating its legal position. Biofrontera AG and its subsidiaries have signed a jointly defense agreement with Biofrontera Inc, to share legal expenses.

Costs for the ITC legal proceedings are expected to amount to US$5 million, to be shared between to two companies. The outlook for the business year 2024 needs to be revised as a result. ?Currently the company is about to establish the effects and will inform about a new outlook once there is more clarity about the situation.

(end)

emitter: Biofrontera AG
address: Hemmelrather Weg 201, 51377 Leverkusen
country: Germany
contact person: Investor Relations
phone: +49 (0) 214 87 63 20
e-mail: ir@biofrontera.com
website: www.biofrontera.com

Still expecting new 52 week highs!

$BFRI

That's how its done don't question the authority! Got to see the angles BEFORE they are Played! another jackpot hit when the clown market makers where playing games I loaded 450k shares the last 3 weeks before the Boom!

Wait for $2.22+ for continuation to the upside could see new 52 week highs 5.23 if that resistance level breaks in the 2.20+ area to the upside. Holding 225k shares houses money I school these clown MM all day . Call me Daddy Buy out in the works IMO!

$BFRI

Next company in the skin care area that will be taken is out id micro cap BFRI 4 Million market with drug that brings them cash flow positive early next year.
https://www.biofrontera-us.com/research/product-pipeline

$RVNC

Double digits on tap.

$PTON

DRUG Coiled Spring wants to move soon. Might add a few by the end of the week could see BFRI have a breakout soon to $5.00-$10.00 one of the most used FDA skin cancers on the market with expanding label and additional indications.

$DRUG

Remember when the stock was a couple bucks a few years back BK coming blah blah this one of my great total ROI from the bottom still holding free shares. Always buy the fear and make the big $ Staggering gains and have made some nice hits on options over the last few years.

$CVNA

Probably Adding $170 strikes for early next year!

$RDDT

The company achieving profitability in first half 2025. This will be further supported by the label change of Ameluz for the use of up to three tubes per treatment from one Tube approved by the FDA with a user fee goal of October 4, 2024.”
Approved for Actinic Keratosis. 13 million patients population.
Approvals coming for Basil Cell & Basal Cell Carcinoma Phase 3
Acne coming
1.3 Million Floating shares 67% owned by Insiders and institutions 5 Million market cap
Wildly undervalued
https://www.healio.com/news/dermatology/20241007/fda-approves-increase-of-ameluz-dosing-from-one-to-three-tubes-for-actinic-keratosis
Ameluz topical gel 10% (aminolevulinic acid hydrochloride, Biofrontera Inc.) is currently the only FDA-approved AK medication for both lesion-directed and field-directed treatment of actinic keratosis. Since AK may affect many areas of both the face and scalp, this approval allows for patients with AK who are undergoing the use Ameluz on larger surface areas and multiple sites.

Typical movement and manipulation before a buyout takes place shaking the tree. I added a lot of shares last 2 weeks and have many friends buying shares one of them wants to buy the company he is a British financier and investor who has bought dozens of companies in Europe and the USA..

$BFRI

100K+ Q1 2025

$BTC

I'm not selling till they announce a buyout $150.00-$200.00

Best in Class Obesity drug in oral and injectable CEO is BL is top shelf executive.

$VKTX

No one liked her at $7.00 but I did. this is a monster in the making.

Quantum computing Leader.

$IONQ

PRQR is WVE 2.0

Glad I loaded the day before the break out!

100k shares long Love the Lily connection and brain power from ALNY at PRQR very early pipeline buy out sooner than later.

Lily owns over 16% of PRQR

$PRQR

seven figure gains I'm holding for $300+

own 5000 shares from my jackpot in options that started buying in 45.00 range.

$MSTR

I have $175.00 very Bullish revenues are quantum leaping!

$ROOT

1500% profits on my options in less than 20 days! I knew it was overheated and sold yesterday!

$DJT

Just cashed in those $100 debit spread call options less than month 489% profit.

AI powered platform enhancing profits company should had their first profitable quarter!

I love RDDT one of the only social media sites I back and use. Very useful platform.

$RDDT

Buyout Merger in the works! You can make Book on That!


https://us.ameluz.com/

https://www.biofrontera-us.com/research/product-pipeline

Basil Cell & Squamous cell carcinoma indication coming soon and Acne not that far behind.

$BFRI

GLYC Sold at .60 yesterday for 203% profit.

Next micro cap buyout or hostile take over will be BFRI interesting price action after hours FDA approved drug for AK skin cancer with late stage pipeline for Basil Cell and Squamous cell carcinoma Phase 3 and Acne Phase 2 call your dermatologist I bet they use Ameluz
the FDA also just green lighted 3 tubes can be used in a single session from 1 $400 a tube =$1200

https://www.biofrontera-us.com/research/product-pipeline

https://www.investing.com/news/company-news/biofrontera-locks-phase-3-sbcc-study-database-for-analysis-93CH-3662035


https://us.ameluz.com/
$GLYC

Big $ is going to send this soon! Book it!
Multiple Skin cancer FDA approved drugs and deep late stage pipeline.
Cash flow positive near term with big drug indications coming to market!
Parabolic move is on the horizon.
2.5 Million floating shares nearly 70% owned by insiders and institutions 4 million dollar market

$BFRI

Starter $7.90

$ANVS

Poetry in motion Send it Dilly!

$CDXS

unreal left a few dollars on the table people are making millions today. I made a measly couple hundred grand.
Watch BFRI 2 million floater thank me later

$DRUG

DRUG jackpot from $3.02-$13.50 in 2 hours this morning swung profits into SGMT and CDXS

BFRI two approved skin cancer drugs 2.5 million float 4 million market cap cash flow positive early 2025. [/color Superficial Basal Cell Carcinoma next approval in the coming months 3 million patients.should break 52 week highs of 8.20 Pipeline alone is worth 50 million dollars.

$DRUG

Great call who ever hit Drug was eyeing it Friday and missed this one BFRI will see a similar move soon!

$DRUG

just loaded another 12 pack.

$CLDX

Next leg up will come in time patience!

$CAPR

We are just getting started I pounded the table to load up in the mid 2's low 3's
LFG!
$SGMT

So easy if you can see the angles before they are played!

$VERB

overlooked Privacy will be key sooner than later in crypto!

$ZEC

New 52 week high of $9.00= fair value for just the pipeline today 1100% ROI=45 million dollar market cap

Cash flow positive in the coming months Roth $16.00 Target last week.

They have one of 2 drugs on the market for a patient population of 13 million for pre cancerous legions the 3 tube = $1200 from $400 for 1 tube in one session approval accelerates revenue BFRI has the superior efficacy and safety record.. @ Xepi 2nd FDA approved drug. Never understood the ones who buy stocks after a parabolic move trend is changing.

Phase 3 Squamous cell carcinoma & basal cell carcinoma updates coming soon.

$20.00 price tag is in the cards the revenue next year should climb hence the 1-3 Tubes + in the coming quarters. + Late stage Phase 3's Skin cancer drugs that are safe and effective. Key Cash flow positive soon unheard of for a biotech under 5 million with a deep pipeline and nearing positive cash flow. Send it!

$BFRI

Yup Their it is like I said got to see the angles before they are played! Unreal!

Now I get to buy some more beaten down bios for my kid.

Denmark's Lundbeck bets on epilepsy drug in $2.6 billion Longboard deal

1000% gains+ for the year here!

$LBPH

Lets F'kn Go

Microstrategy Stock MSTR Soars 1,620% — Outshining Bitcoin, S&P 500, and the Magnificent 7.
https://news.bitcoin.com/microstrategy-stock-mstr-soars-1620-outshining-bitcoin-sp-500-and-the-magnificent-7/

$MSTR